Loading...
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan
1. The aim of this study was to establish how thromboxane receptors (TP) respond to the increase in levels of plasma thromboxane observed in both cardiac (cardiomyopathy, ischaemic heart disease and pulmonary hypertension) and vascular disease (atherosclerosis of coronary artery disease and accelera...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2001
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1573097/ https://ncbi.nlm.nih.gov/pubmed/11724743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0704416 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|